European School

Malta Announces Addition of International Energy Executive Philippe Delleville to Senior Management Team

Retrieved on: 
Tuesday, May 17, 2022
Other Energy, Environment, Utilities, Coal, Alternative Energy, Energy, Chevron Corporation, Export–Import Bank of the United States, MBA, Temple University, Breakthrough Energy, Alfa Laval, Leadership, Electricity, PHES, EXIM, Inc., Wind, New product development, European School, Heat, Exim Bank, Pruning shears, Service, Reims Management School, Development finance institution, Chairperson, Renewable energy, Management

Malta Inc., a leading innovator of grid-scale, long-duration energy storage (LDES), announced today the addition of Philippe (Phil) Delleville as Managing Director of Product Development, Strategy and Operations.

Key Points: 
  • Malta Inc., a leading innovator of grid-scale, long-duration energy storage (LDES), announced today the addition of Philippe (Phil) Delleville as Managing Director of Product Development, Strategy and Operations.
  • Delleville joins Malta with extensive global business development acumen, having served in catalytic management positions with major national and international energy corporations.
  • In this position, Delleville oversaw over $4 billion in project financing and supported approximately 4 gigawatts worth of wind energy projects.
  • Phil Dellevilles galvanizing approach to organizational development and project finance makes his addition to our team an exciting moment in the Malta Inc. journey, said Malta CEO Ramya Swaminathan.

Catalyst Advisors LP Announces Partner and Director Promotions

Retrieved on: 
Tuesday, January 11, 2022
Science, Professional Services, Other Science, Human Resources, Ulster, Virginia Tech Corporate Research Center, European School, University, Library science, Growth, Bachelor of Science, ESCP Business School, Learning, Research, Celebrity board director, Solution, Global, Catalysis, Ecosystem, Literature, University of Washington Information School, Master of Science, Customer, Microsoft, Organization, Management, Sales

Catalyst Advisors LP, an international executive recruitment and assessment firm singularly focused on life sciences, announced several executive promotions to support the firms growth.

Key Points: 
  • Catalyst Advisors LP, an international executive recruitment and assessment firm singularly focused on life sciences, announced several executive promotions to support the firms growth.
  • These leaders will continue to support Catalyst Advisors ongoing efforts to build transformational boardrooms and executive leadership teams for organizations making life-changing scientific contributions.
  • Our focus is to elevate rising leaders and reward their hard work to enable them to better serve our clients, said John Archer, Founder and Partner at Catalyst Advisors.
  • Based in Seattle, Amy Bottoms joined Catalyst Advisors six years ago with more than 25 years of life sciences recruiting experience.

Kriya Therapeutics Appoints Theresa Heah, M.D., MBA as Chief Medical Officer and President of Kriya Ophthalmology™, a Newly Launched Division of Kriya Therapeutics

Retrieved on: 
Thursday, October 14, 2021
Biotechnology, Health, Genetics, Pharmaceutical, Optical, Leadership, Ophthalmology, Technology, MBA, Silicon, LinkedIn, Management, University of London, Degenerative disease, Applied Genetic Technologies Corporation, Therapy, Geographic atrophy, Lists of diseases, Multimedia, ESMT, Eye, Patient, Business administration, Bayer, University, Aerie Pharmaceuticals, Triangle Park (Quezon City), European School, Uveitis, Oklahoma Office of the Chief Medical Examiner, Entrepreneurship, Quality of life, Pharmaceutical industry

Kriya Therapeutics, Inc. , a fully integrated company pioneering novel technologies and therapeutics in gene therapy, today announced the appointment of Theresa Heah, M.D., MBA as Chief Medical Officer and President of Kriyas newly launched ophthalmology division, Kriya Ophthalmology.

Key Points: 
  • Kriya Therapeutics, Inc. , a fully integrated company pioneering novel technologies and therapeutics in gene therapy, today announced the appointment of Theresa Heah, M.D., MBA as Chief Medical Officer and President of Kriyas newly launched ophthalmology division, Kriya Ophthalmology.
  • View the full release here: https://www.businesswire.com/news/home/20211014005346/en/
    Theresa Heah, M.D., MBA, Chief Medical Officer and President of Kriya Ophthalmology (Photo: Business Wire)
    Kriya Ophthalmology is focused on the discovery and development of transformative gene therapies for ocular diseases with high unmet need.
  • Kriya Ophthalmology is currently advancing therapeutic programs in uveitis, geographic atrophy and additional undisclosed disease areas.
  • We are thrilled to welcome Theresa to lead Kriya Ophthalmology, said Ilise Lombardo, M.D., Chief Medical Officer of Kriya Therapeutics.